Last reviewed · How we verify
Choriongonadotropin
Choriongonadotropin is a Small molecule drug developed by Ferring Pharmaceuticals. It is currently FDA-approved. Also known as: Brevactid®, human chorionic gonadotropin (hCG).
At a glance
| Generic name | Choriongonadotropin |
|---|---|
| Also known as | Brevactid®, human chorionic gonadotropin (hCG) |
| Sponsor | Ferring Pharmaceuticals |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- hCG Priming in Women With Diminished Ovarian Reserve (PHASE3)
- A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial (PHASE4)
- Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer (NA)
- Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Choriongonadotropin CI brief — competitive landscape report
- Choriongonadotropin updates RSS · CI watch RSS
- Ferring Pharmaceuticals portfolio CI
Frequently asked questions about Choriongonadotropin
What is Choriongonadotropin?
Choriongonadotropin is a Small molecule drug developed by Ferring Pharmaceuticals.
Who makes Choriongonadotropin?
Choriongonadotropin is developed and marketed by Ferring Pharmaceuticals (see full Ferring Pharmaceuticals pipeline at /company/ferring).
Is Choriongonadotropin also known as anything else?
Choriongonadotropin is also known as Brevactid®, human chorionic gonadotropin (hCG).
What development phase is Choriongonadotropin in?
Choriongonadotropin is FDA-approved (marketed).
Related
- Manufacturer: Ferring Pharmaceuticals — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Brevactid®, human chorionic gonadotropin (hCG)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing